Endo Health Solutions Inc.: Record $1.536 Billion Fine for Opana ER Deception Fuels Opioid Crisis

Endo Health Solutions Inc. Hit with Record $1.536 Billion Fine for Misleading Claims about Opana ER Safety

Bankrupt Endo Health Solutions Inc. Admits to Deceptive Tactics in Opana ER Marketing, Faces Landmark Penalty

According to WashingTonExaminer, A big decision was made on Friday when a judge told a pharmaceutical company called Endo Health Solutions Inc. to pay a huge fine of $1.536 billion. This happened because the company misled doctors about the safety of a drug called Opana ER with INTAC. It’s the second-largest fine ever given to a drug company for breaking the law. Endo Health Solutions Inc. had already declared bankruptcy before this decision.

The company admitted that its sales managers and representatives were telling doctors that Opana ER was safe from abuse and tampering, even though it wasn’t true. They even showed fake demonstrations, like hitting sample pills with hammers, to make it look like the drug couldn’t be crushed or tampered with.

READ ALSO: IRS Unveils Strategic Plan To Tackle Tax Gap With IRA Funds: Focus On High-Income Taxpayers And Large Corporations!

Endo Health Solutions Inc.: Record $1.536 Billion Fine for Opana ER Deception Fuels Opioid Crisis (PHOTO: Philadelphia)

Endo Health Solutions Inc. Blamed for Fueling Opioid Crisis, Faces Ongoing Restrictions and Hefty Financial Penalties

The U.S. Department of Justice said that this kind of behavior from companies like Endo Health Solutions Inc. has contributed to the ongoing opioid crisis. Even though the company has gone through bankruptcy, it’s still held responsible for its actions. Now, it has strict rules against selling opioids and has to pay a big chunk of money to help deal with the opioid crisis.

READ ALSO: Nearly $650K Fine: U.S. Department Of Labor Found Tennessee Cleaning Company Illegally Hiring Minors In Slaughterhouses!